INVESTMENTS TO ADDRESS HEALTH INEQUITIES IN PROSTATE CANCER CARE Movember funds three Australian programs targeting under-served populations
SEGMENT
Filmed in Melbourne | February 2025
INTERVIEWS
Sarah Weller
Global Director – Prostate Cancer, Movember
Kris Bennett,
Director – Prostate Cancer Health Equity, Movember
Movember is committed to advancing new research, cutting-edge treatments, and healthy behaviours, and advocating for inclusive, gender-responsive healthcare that caters to the unique needs of men, women, and gender-diverse individuals from diverse cultural backgrounds. In doing so, they hope to forge a future where barriers to healthy living are overcome, stigmas are removed, and where everyone has an equal opportunity to live a long, healthy life.
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
AUSTRALIAN FUNDING FOR TARGETED PROSTATE CANCER CARE OUTREACH PROGRAMS
– The prostate cancer mortality rate in remote areas is almost 20% higher than in major cities. Access to treatment is the leading cause. This equity gap is what the Royal Flying Doctor Service of Australia’s grant will address, to improve access to and use of prostate cancer treatment services in rural and remote areas.
– Currently, prostate cancer data on the culturally and linguistically diverse communities of South Western Sydney is insufficient. That’s the first roadblock to improving this historically overlooked group’s prostate cancer care. The George Institute for Global Health aims to fill in the blanks with population level data to help close this equity gap.
– Australian Prostate Centre will create culturally appropriate prostate cancer services and practices for the LGBTQIA+ community, to counter the fear of discrimination and stigma that often stands in its way of getting prostate cancer screenings and diagnoses.
Australian Health Journal spoke with Movember about these targeted outreach programs in Australia and the hope they will help provide education and empower historically and intentionally excluded communities, using community stakeholders and voices to build trust. Collaborations with healthcare providers, academic institutions, and community-based organisations will share resources and expertise to develop tailored solutions.
You Might also like
-
Expansion of specialist training in regional & rural areas
Associate Professor Sanjay Jeganathan, Chair of the Council of Presidents of Medical Colleges (CPMC) states, ”Our rural and regional communities deserve the same access to specialist care as our cities. We’re seeing real results from our colleges’ commitment to rural training.”
-
Contrasting Population Needs and Alternative Funding Models
Dr Jaspreet Saini is a GP with a decade of experience, practicing in West Pennant Hills and Rooty Hill, New South Wales. He began his medical journey at Monash University, followed by internships and residency at Blacktown Hospital, in Western Sydney. Instead of confining himself to a single specialty, he pursued general practice to explore various facets of medicine.
-
Report gives insights to clinical trial activity in Australia
Established in 2024, Bellberry is a Adelaide-based national, not-for-profit organisation that provides streamlined scientific and ethical reviews of human research. It is the 2025 winner of the Championing Health Award in the Telstra Best of Business Awards.
Australian Health Journal spoke with Bellberry Limited CEO, Kylie Sproston on the organisation and the findings in activity documented in the Clinical Trial Activity Report (CTAR) 2024.